Sagent Pharma

Sagent Pharmaceuticals is a specialty pharmaceutical company that focuses on the development, manufacturing, and marketing of generic injectable products. Founded in 2006 and headquartered in Schaumburg, Illinois, the company provides a diverse portfolio of anti-infectives, oncology treatments, and critical care medications primarily for the hospital market. Sagent is known for its Discover, Develop, and Deliver business model, which emphasizes a global supply chain to ensure product availability and combat drug shortages. In 2016, the company was acquired by Nichi-Iko Pharmaceutical Co., Ltd., Japan's largest generic drug manufacturer, to expand its global reach and biosimilar capabilities. Today, Sagent continues to operate as a key subsidiary, maintaining significant manufacturing facilities in the United States.